Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination

    Not recruiting

    3 1 1
    France Germany Spain
  • Study on the Effects of VH4524184 for Adults Newly Diagnosed with HIV

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Spain
  • Study on Switching to Islatravir and MK-8507 for Adults with HIV-1 Who Are Virologically Suppressed on a Drug Combination

    Not recruiting

    2 1 1
    Investigated Diseases:
    France
  • Study on Reversing HIV Latency Using Pyrimethamine, Lenalidomide, and Panobinostat for People Living with HIV

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Safety and Effects of Dasatinib for Reducing Inflammation in People with HIV on Antiretroviral Therapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on the Safety of Doravirine and Islatravir for HIV Patients Who Previously Participated in Doravirine/Islatravir Trials

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy
  • Study Comparing Bictegravir/Lenacapavir to Current Therapy in People with HIV-1 Who Are Successfully Treated

    Not recruiting

    3 1 1
    France Germany Italy Spain
  • Study Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium France Germany Ireland Italy Spain
  • Study on Switching HIV Treatment to Dolutegravir/Lamivudine in Patients Aged 50+ with Virologic Suppression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium France Germany Italy The Netherlands +2